# E004 A2 Public Threshold-Evidence Discovery — 2026-08-27

**Spec:** 007 SFT V1  
**Related control plane:** Spec 005 A2 scientific threshold/margin readiness  
**Canonical research base:** `446ac00a8466de8de243f300abdce0ec33d36e57`  
**Lifecycle:** public research only  
**Authority effect:** NONE

This packet records a bounded read-only public-literature discovery pass for the six Spec 005 hard-gate population metrics. Its purpose is to identify useful scientific context and method candidates for later qualified clinical/statistical review.

It does **not** freeze a numeric threshold, margin, target coverage, confidence level, sample size, power target, reviewer identity, suite identity, metric implementation, or Founder decision. It does not make any hard gate ready to freeze and does not create, revoke, replace, or widen any existing E002/E003 authority.

```text
A2_PUBLIC_EVIDENCE_DISCOVERY_ONLY=YES
A2_NUMERIC_THRESHOLD_FREEZE_AUTHORITY=NONE
A2_CLINICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
A2_STATISTICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
A2_CANONICAL_GOVERNANCE_ADOPTION=NOT_PERFORMED
HARD_GATE_POPULATION_THRESHOLDS_READY_TO_FREEZE=0
HARD_GATE_POPULATION_THRESHOLDS_NOT_READY_TO_FREEZE=6

MODEL_WEIGHT_ACCESS_AUTHORITY=AUTHORIZED_E002_FROZEN_PUBLIC_CANDIDATES_ONLY
MODEL_EXECUTION_AUTHORITY=AUTHORIZED_E003_FROZEN_TOURNAMENT_ONLY
BENCHMARK_PAYLOAD_ACCESS_AUTHORITY=AUTHORIZED_E003_A15_BOUND_PUBLIC_TOURNAMENT_INPUTS_ONLY
BENCHMARK_PAYLOAD_EXECUTION_AUTHORITY=AUTHORIZED_E003_A15_BOUND_PUBLIC_TOURNAMENT_INPUTS_ONLY
DEVICE_EXECUTION_AUTHORITY=AUTHORIZED_E003_FROZEN_TOURNAMENT_QUALIFICATION_ONLY

CONTAMINATION_ASSESSMENT_PAYLOAD_ACCESS_AUTHORITY=NONE
MODEL_CONVERSION_AUTHORITY=NONE
TRAINING_AUTHORITY=NONE
PRIVATE_GOLD_ACCESS_AUTHORITY=NONE
PROVIDER_GENERATION_AUTHORITY=NONE
PHI_ACCESS_AUTHORITY=NONE
GATED_ASSET_ACCESS_AUTHORITY=NONE
SPEND_AUTHORITY=NONE
CURRENT_AUTHORIZED_SPEND_USD=0

E004_STATE=BLOCKED_PREFLIGHT
E004_EXECUTION_OCCURRED=NO
```

The bounded E002/E003 authorities above are **not currently executable** because the canonical E004 preflight is blocked. This packet records that blocked state; it does not reinterpret bounded authorization as revocation.

## 1. Canonical A2 question

The canonical threshold contract requires, before any statistical threshold may freeze:

```text
INTENDED_USE_AND_POPULATION
EVALUATION_DESIGN
IDENTITY_BOUND_EVIDENCE
CLINICAL_REVIEW_AUTHORITY
STATISTICAL_RATIONALE
SAMPLE_SIZE_OR_POWER_RATIONALE
CANONICAL_GOVERNANCE_ADOPTION
```

The six hard-gate population metrics are:

```text
emergency_miss_rate
medication_critical_error_rate
selective_risk_at_target_coverage
citation_entailment_fidelity
arabic_clinical_parity_gap
lab_report_field_extraction_accuracy
```

This packet asks only:

> Does current public evidence provide useful scientific context or method candidates for later expert review, and does any source justify copying a universal numeric threshold directly into commandMed?

Current result:

```text
PUBLIC_METHOD_OR_RISK_CONTEXT_EVIDENCE_FOUND=YES
UNIVERSALLY_TRANSFERABLE_COMMANDMED_NUMERIC_THRESHOLD_FOUND=NO
A2_THRESHOLD_FREEZE_STATUS_CHANGED=NO
```

## 2. Current metrics-v2 reconciliation state

Session 9 Q5 was captured before A1 metrics-v2 corrective maintenance and recorded an Arabic-parity evidence-role conflict because historical V1 exposed one `required_evidence` string tied to `COMMANDMED_ARABIC_GOLD` while Private Gold is forbidden for selection.

That **schema/evidence-role conflict is no longer current**.

Canonical A1 metrics-v2 now exists with:

```text
V2_SCHEMA_ID=commandmed-metrics-catalog
V2_SCHEMA_VERSION=2.0
V2_CATALOG_PATH=data/eval/metrics-v2.json
V2_METRICS_SHA256=bad51bffe30c0fb7de37afcaf8620ad1ad2deed2dd626a1ec6c2eb47c4107f4b
```

For `arabic_clinical_parity_gap`, V2 machine-readably separates:

```text
SELECTION_DEV
  purpose=CHECKPOINT_SELECTION
  source_policy=SELECTION_SAFE_NON_GOLD

PRIVATE_GOLD_FINAL_AUDIT
  purpose=PRIVATE_GOLD
  source_policy=PRIVATE_GOLD_FAMILY
```

Therefore:

```text
ARABIC_PARITY_V1_SINGLE_ROLE_CONFLICT=HISTORICAL_SUPERSEDED_BY_A1_V2_FOR_V2_CONSUMERS
ARABIC_PARITY_V2_EVIDENCE_ROLE_SCHEMA_CONFLICT=RESOLVED
PRIVATE_GOLD_SELECTION_PROHIBITION=PRESERVED
PRIVATE_GOLD_FINAL_AUDIT_ROLE=PRESERVED
```

A1 did **not** bind a real selection-safe Arabic suite, freeze a numeric parity threshold, appoint reviewers, or authorize Private Gold access. Arabic parity therefore remains `NOT_READY_TO_FREEZE`, but no longer because the V2 schema itself requires Private Gold for selection.

This packet treats Session 9 Q5 as historical readiness evidence and recomputes current Arabic blocker semantics from canonical metrics-v2.

## 3. Cross-cutting public governance context

### 3.1 WHO — intended-use-specific validation

WHO's *Regulatory considerations on artificial intelligence for health* states that evaluation of AI performance claims requires a clear use-case description plus analytical and clinical validation, including safety/performance evidence and bias/discrimination assessment.

Source:

- `https://www.who.int/publications/i/item/9789240078871`

Disposition:

```text
WHO_SOURCE_SUPPORTS_INTENDED_USE_SPECIFIC_VALIDATION=YES
WHO_SOURCE_SUPPLIES_COMMANDMED_METRIC_SPECIFIC_NUMERIC_THRESHOLD=NO
```

### 3.2 FDA — intended use, inputs, methods, and clinical validation

FDA's January 2026 *Clinical Decision Support Software* final guidance emphasizes intended use, users/patients, medical inputs, methods/data, and clinical validation sufficient for independent review of recommendation bases.

Sources:

- `https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software`
- `https://www.fda.gov/medical-devices/digital-health-center-excellence/step-6-software-function-intended-provide-clinical-decision-support`

Disposition:

```text
FDA_SOURCE_SUPPORTS_INTENDED_USE_AND_VALIDATION_BINDING=YES
FDA_SOURCE_SUPPLIES_COMMANDMED_UNIVERSAL_NUMERIC_THRESHOLD=NO
```

### 3.3 American Heart Association — risk-proportionate evaluation

The AHA science advisory *Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care* was published in 2025 and proposes pragmatic, risk-proportionate health-AI evaluation and monitoring.

- PMID `41208719`
- DOI `10.1161/CIR.0000000000001400`
- `https://pubmed.ncbi.nlm.nih.gov/41208719/`

A 2026 erratum does not convert the advisory into a 2026 publication.

Disposition:

```text
AHA_SOURCE_SUPPORTS_RISK_PROPORTIONATE_EVALUATION=YES
AHA_SOURCE_SUPPLIES_COMMANDMED_NUMERIC_THRESHOLDS=NO
```

These cross-cutting sources support the existing governance architecture. They do not replace metric-specific evidence.

## 4. `emergency_miss_rate`

Canonical evidence need:

```text
REQUIRED_EVIDENCE=Clinical adjudication panel on emergency evaluation suite
CLINICAL_DOMAIN_REVIEW=RELEVANT_ACUTE_OR_EMERGENCY_CLINICAL_REVIEW
STATISTICAL_METHOD_REVIEW=REQUIRED
```

Public evidence candidates:

1. Prospective ED chatbot triage study, 500 patients. Compared with emergency physicians, ChatGPT under-triaged 26.5% of yellow-coded and 42.6% of red-coded patients; the authors concluded sole reliance on the evaluated AI models was not appropriate.
   - PMID `39420246`
   - DOI `10.1080/00325481.2024.2418806`
   - `https://pubmed.ncbi.nlm.nih.gov/39420246/`
2. Systematic review of prospective AI triage studies, published in 2025, covering model performance, workflow, under-triage, and over-triage outcomes.
   - PMID `39262027`
   - DOI `10.1111/jnu.13024`
   - `https://pubmed.ncbi.nlm.nih.gov/39262027/`
3. 2026 retrospective evaluation of seven LLMs in 39,375 ED patients. Performance was inconsistent; the authors characterized current LLMs as more suitable for supervised support than autonomous triage.
   - PMID `41753200`
   - DOI `10.3390/jcm15041512`
   - `https://pubmed.ncbi.nlm.nih.gov/41753200/`

Discovery disposition:

```text
EMERGENCY_PUBLIC_RISK_CONTEXT=FOUND
EMERGENCY_PUBLIC_METHOD_CONTEXT=FOUND
EMERGENCY_TRANSFERABLE_NUMERIC_THRESHOLD=NOT_ESTABLISHED
EMERGENCY_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

The studies differ in triage scale, population, model role, comparator, and intended use. Their observed rates are not commandMed policy thresholds.

## 5. `medication_critical_error_rate`

Canonical evidence need:

```text
REQUIRED_EVIDENCE=Deterministic drug-interaction lookup and clinical pharmacology review
REQUIRED_RESULT_IDENTITY_FIELDS=source_id,source_revision,result_digest
CLINICAL_DOMAIN_REVIEW=RELEVANT_MEDICATION_OR_PHARMACOLOGY_SAFETY_REVIEW
STATISTICAL_METHOD_REVIEW=REQUIRED
```

Public evidence candidates:

1. 2025 case-based evaluation of complex ICU medication regimens. Clinicians identified a median 4.1–6.9 medication errors per recommended regimen; life-threatening recommendations occurred in 16.3%–57.1% of regimens depending on LLM.
   - PMID `41368579`
   - DOI `10.3389/fphar.2025.1514445`
   - `https://pubmed.ncbi.nlm.nih.gov/41368579/`
2. Prospective cross-over medication-safety study across 16 specialties. A pharmacist+LLM co-pilot strategy performed best overall and improved serious-harm error detection relative to pharmacist alone in that study.
   - PMID `40997804`
   - DOI `10.1016/j.xcrm.2025.102323`
   - `https://pubmed.ncbi.nlm.nih.gov/40997804/`
3. Rx-LLM benchmarking suite. Performance varied materially across medication tasks and no model was uniformly superior.
   - PMID `41404284`
   - DOI `10.64898/2025.12.01.25341004`
   - `https://pubmed.ncbi.nlm.nih.gov/41404284/`
4. DDI-alert systematic review/meta-analysis. Overall clinician override prevalence was approximately 90%, illustrating that alert prevalence/override is not a direct proxy for clinically critical medication error rate.
   - PMID `38899788`
   - DOI `10.1177/14604582241263242`
   - `https://pubmed.ncbi.nlm.nih.gov/38899788/`

Discovery disposition:

```text
MEDICATION_PUBLIC_RISK_CONTEXT=FOUND
MEDICATION_PUBLIC_METHOD_CONTEXT=FOUND
MEDICATION_TRANSFERABLE_NUMERIC_THRESHOLD=NOT_ESTABLISHED
MEDICATION_AUTHORITATIVE_LOOKUP_IDENTITY_FOR_SPEC005=UNRESOLVED
MEDICATION_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

## 6. `selective_risk_at_target_coverage`

Canonical evidence need:

```text
REQUIRED_EVIDENCE=Abstention curve evaluation on calibrated holdout suite
EXACT_TARGET_COVERAGE=NOT_YET_FROZEN
EXACT_ACCEPTABLE_RISK_THRESHOLD_OR_MARGIN=NOT_YET_FROZEN
```

Public evidence candidates:

1. Healthcare selective-prediction methodology with coverage guarantees.
   - PMID `34854476`
   - DOI `10.1111/biom.13612`
   - `https://pubmed.ncbi.nlm.nih.gov/34854476/`
2. 2026 conformal selective prediction for clinical triage under distribution shift. The study reports an 80% coverage operating point for retained-case error analysis, uses a held-out calibration set, and chooses deferral through a task-specific clinical cost model. It also reports a nominal 90% conformal coverage target and a separate 95% sensitivity target; these are distinct quantities and are not interchangeable commandMed targets.
   - PMID `41721063`
   - DOI `10.1038/s41598-026-40637-w`
   - `https://pubmed.ncbi.nlm.nih.gov/41721063/`
3. 2026 review and decision-theoretic framework for LLM abstention in healthcare, emphasizing uncertainty-driven and safety-driven abstention rather than a universal confidence cutoff.
   - PMID `42298124`
   - DOI `10.1038/s41746-026-02882-1`
   - `https://pubmed.ncbi.nlm.nih.gov/42298124/`

Discovery disposition:

```text
SELECTIVE_RISK_PUBLIC_METHOD_CONTEXT=FOUND_STRONG
SELECTIVE_RISK_UNIVERSAL_TARGET_COVERAGE=NOT_ESTABLISHED
SELECTIVE_RISK_UNIVERSAL_ACCEPTABLE_RISK=NOT_ESTABLISHED
SELECTIVE_RISK_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

No published operating point is copied into commandMed.

## 7. `citation_entailment_fidelity`

Canonical evidence need:

```text
REQUIRED_EVIDENCE=Deterministic verifier + clinician audit on citation-backed responses
EXACT_DETERMINISTIC_VERIFIER_IDENTITY=UNRESOLVED
EXACT_CLINICIAN_AUDIT_PROTOCOL_AND_AUTHORITY_IDENTITIES=UNRESOLVED
```

Public evidence candidate:

- Wu et al., *An automated framework for assessing how well LLMs cite relevant medical references*, Nature Communications (2025), introduces SourceCheckup. The study evaluates statement/source support in medical responses and reports automated-verifier agreement with consensus from three US-licensed medical experts.
  - DOI `10.1038/s41467-025-58551-6`
  - `https://www.nature.com/articles/s41467-025-58551-6`

Discovery disposition:

```text
CITATION_PUBLIC_VERIFICATION_METHOD_CONTEXT=FOUND_STRONG
CITATION_PUBLIC_CLINICIAN_VALIDATION_PRECEDENT=FOUND
CITATION_TRANSFERABLE_NUMERIC_THRESHOLD=NOT_ESTABLISHED
CITATION_EXACT_COMMANDMED_VERIFIER_IDENTITY=UNRESOLVED
CITATION_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

The paper is useful for verifier/audit design; its measured support rates are not a commandMed population threshold.

## 8. `arabic_clinical_parity_gap`

Current V2 evidence-role schema is structurally reconciled as described in Section 2. Remaining evidence need is selection-safe paired Arabic-English clinical evidence plus qualified review and threshold/statistical design.

Public evidence candidates:

1. *Cross-Lingual Empirical Evaluation of Large Language Models for Arabic Medical Tasks* (2026) reports a persistent Arabic/English performance gap that worsens with task complexity and analyzes Arabic tokenization and reliability.
   - arXiv `2602.05374`
   - `https://arxiv.org/abs/2602.05374`
2. MedArabiQ (2025) introduces seven Arabic medical tasks and reports cross-model variability, supporting explicit Arabic-domain evaluation.
   - arXiv `2505.03427`
   - `https://arxiv.org/abs/2505.03427`
3. Current canonical metrics-v2 requires matched Arabic-English task-pair evidence from an identity-bound selection-safe development suite for the selection role. Public literature does not itself bind that commandMed suite.

Discovery disposition:

```text
ARABIC_PUBLIC_DISPARITY_EVIDENCE=FOUND
ARABIC_PUBLIC_METHOD_CONTEXT=FOUND
ARABIC_TRANSFERABLE_MAXIMUM_GAP=NOT_ESTABLISHED
ARABIC_V2_EVIDENCE_ROLE_SCHEMA_CONFLICT=RESOLVED_BY_A1
ARABIC_SELECTION_SAFE_PAIRED_EVIDENCE_IDENTITY=UNRESOLVED
ARABIC_EXACT_NUMERIC_THRESHOLD=NOT_YET_FROZEN
ARABIC_EXACT_PAIRED_ANALYSIS_METHOD=NOT_YET_FROZEN
ARABIC_EXACT_CLINICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
ARABIC_EXACT_STATISTICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
ARABIC_EXACT_SAMPLE_SIZE_OR_POWER_DERIVATION=NOT_YET_FROZEN
ARABIC_PARITY_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

Private Gold remains a separate non-selection final-audit role and is not accessed by this research.

## 9. `lab_report_field_extraction_accuracy`

Canonical evidence need:

```text
REQUIRED_EVIDENCE=Deterministic field comparator against curated lab fixtures
EXACT_SELECTION_DEV_CURATED_FIXTURE_IDENTITIES=UNRESOLVED
EXACT_FIELD_SCHEMA_AND_COMPARATOR_IDENTITIES=UNRESOLVED
```

Public evidence candidates:

1. 2023 laboratory-report extraction study on 153 paper reports, reporting overall information-extraction F1 around 0.86 across test item, result, unit, and reference-range entities.
   - PMID `37932733`
   - DOI `10.1186/s12911-023-02346-6`
   - `https://pubmed.ncbi.nlm.nih.gov/37932733/`
2. Clinical laboratory NLP evaluation on 87,500 unique reports reporting overall micro-F1 above 94% with materially lower performance for some rarer labels.
   - PMID `38875570`
   - `https://pubmed.ncbi.nlm.nih.gov/38875570/`

Discovery disposition:

```text
LAB_PUBLIC_PERFORMANCE_CONTEXT=FOUND
LAB_PUBLIC_METHOD_CONTEXT=FOUND
LAB_TRANSFERABLE_MINIMUM_F1=NOT_ESTABLISHED
LAB_EXACT_COMMANDMED_FIXTURE_IDENTITY=UNRESOLVED
LAB_EXACT_COMMANDMED_COMPARATOR_IDENTITY=UNRESOLVED
LAB_THRESHOLD_FREEZE_READINESS=NOT_READY_TO_FREEZE
```

Reported F1 depends on report type, field definition, prevalence, comparator semantics, and validation design. It is not a universal commandMed minimum.

## 10. Current evidence-transfer classification

| Metric | Risk/context evidence | Method-design evidence | Direct commandMed numeric threshold evidence | Current readiness |
|---|---|---|---|---|
| `emergency_miss_rate` | `FOUND` | `FOUND` | `NO` | `NOT_READY_TO_FREEZE` |
| `medication_critical_error_rate` | `FOUND` | `FOUND` | `NO` | `NOT_READY_TO_FREEZE` |
| `selective_risk_at_target_coverage` | `FOUND` | `FOUND_STRONG` | `NO` | `NOT_READY_TO_FREEZE` |
| `citation_entailment_fidelity` | `FOUND` | `FOUND_STRONG` | `NO` | `NOT_READY_TO_FREEZE` |
| `arabic_clinical_parity_gap` | `FOUND` | `FOUND` | `NO` | `NOT_READY_TO_FREEZE` |
| `lab_report_field_extraction_accuracy` | `FOUND` | `FOUND` | `NO` | `NOT_READY_TO_FREEZE` |

`NO` in the numeric-threshold column means this bounded research pass found no source that can responsibly be copied as commandMed policy under the current intended-use/evidence contract. It is not a claim that no future evidence can support a threshold.

## 11. Why external numbers are not copied

Public studies expose empirical operating points and observed performance under different populations, tasks, model roles, comparators, and evaluation designs. Those values can inform method design and evidence appraisal, but copying them into commandMed would violate the repository's pre-result, intended-use-specific, evidence-bound threshold governance.

```text
EXTERNAL_STUDY_RESULT_EQUALS_COMMANDMED_THRESHOLD=NO
LITERATURE_OPERATING_POINT_EQUALS_COMMANDMED_POLICY=NO
BEST_PUBLISHED_MODEL_PERFORMANCE_EQUALS_MINIMUM_ACCEPTABLE_THRESHOLD=NO
ROUNDING_EXTERNAL_RESULT_INTO_POLICY=PROHIBITED
```

## 12. What this pass materially advances

The pass provides a public source inventory for later qualified review and corrects the current-state interpretation of Arabic parity after A1 metrics-v2.

Potential downstream uses, all still separately governed:

1. intended-use and harm framing;
2. comparator and adjudication design;
3. uncertainty/risk-coverage method selection;
4. clinical-audit and deterministic-verifier design;
5. subgroup and language stratification;
6. robustness/external-validation expectations;
7. evidence appraisal and limitations statements.

It does not supply real A2 records.

```text
A2_PUBLIC_EVIDENCE_SOURCE_INVENTORY=AVAILABLE_FOR_LATER_REVIEW
A2_ARABIC_V2_STATE_RECONCILED_TO_CURRENT_CANONICAL_METRICS=YES
A2_REAL_THRESHOLD_RECORDS_CREATED=0
A2_REAL_REVIEW_DISPOSITIONS_CREATED=0
A2_REAL_NUMERIC_THRESHOLDS_FROZEN=0
```

## 13. Remaining A2 blockers

```text
EXACT_IDENTITY_BOUND_SELECTION_DEV_EVIDENCE_PACKAGES=UNRESOLVED
EXACT_PRIMARY_SELECTION_MANIFEST=NOT_YET_FROZEN
EXACT_CLINICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
EXACT_STATISTICAL_REVIEW_AUTHORITY_IDENTITIES=UNRESOLVED
EXACT_REVIEWER_COUNT_OR_QUORUM=UNRESOLVED
EXACT_DISAGREEMENT_RESOLUTION_PROTOCOL=UNRESOLVED
EXACT_NUMERIC_THRESHOLDS_OR_MARGINS=NOT_YET_FROZEN
EXACT_UNCERTAINTY_METHODS_BY_METRIC=NOT_YET_FROZEN
EXACT_SAMPLE_SIZE_OR_POWER_DERIVATIONS=NOT_YET_FROZEN
CANONICAL_GOVERNANCE_ADOPTION_OF_NUMERIC_THRESHOLDS=NOT_PERFORMED
ARABIC_SELECTION_SAFE_PAIRED_EVIDENCE_IDENTITY=UNRESOLVED
```

The previous V1 Arabic evidence-role conflict is **not** listed as a current blocker because A1 metrics-v2 machine-readably repaired that role separation for V2 consumers.

Actual contamination results remain later than a frozen suite and separate contamination-assessment authority. This packet authorizes neither.

## 14. Next dependency-safe work classes

Without expanding authority, later work may:

1. bind exact publication/DOI/PMID identities and limitations into draft evidence-package metadata;
2. identify candidate statistical methods without choosing numeric inputs post hoc;
3. prepare review templates for qualified clinical and statistical reviewers without appointing or impersonating them;
4. research candidate selection-safe source classes for the future paired Arabic-English suite without accessing/creating payloads;
5. reconcile any remaining stale documentation against canonical A1 metrics-v2 where needed.

Actions with **no current authority** remain prohibited:

- freezing numeric thresholds without the required scientific/review evidence;
- claiming qualified review without actual reviewers;
- provider generation of a selection suite;
- contamination-assessment payload access/execution;
- model conversion;
- training;
- Private Gold access;
- PHI/gated asset access;
- spend/payment execution.

Separately, E002/E003 already provide bounded authority for model-weight access, frozen-tournament model execution, A15-bound public benchmark input access/execution, and frozen tournament device qualification. Those actions remain **non-executable while E004 preflight is blocked** and must not be performed by this research packet.

## 15. Research-pass result

```text
A2_PUBLIC_EVIDENCE_DISCOVERY_RESULT=METHOD_AND_RISK_CONTEXT_FOUND_NO_TRANSFERABLE_NUMERIC_POLICY
A2_ARABIC_V2_SCHEMA_RECONCILIATION=RESOLVED_CANONICAL_A1
HARD_GATE_POPULATION_THRESHOLDS_READY_TO_FREEZE=0
HARD_GATE_POPULATION_THRESHOLDS_NOT_READY_TO_FREEZE=6
A2_STATE=INCOMPLETE_REAL_EVIDENCE_AND_REVIEW_REQUIRED
E004_STATE=BLOCKED_PREFLIGHT
E004_EXECUTION_OCCURRED=NO
BACKBONE_WINNER=NEEDS_EVIDENCE
TRAINING_AUTHORITY=NONE
CURRENT_AUTHORIZED_SPEND_USD=0
```

## 16. Non-events

No benchmark, selection-suite, Private Gold, PHI/restricted, model-weight, GGUF, credential, device, payment, or provider payload was accessed. No model, benchmark, contamination, conversion, quantization, device, tournament, or training execution occurred. External work in this packet was read-only public literature/governance research.